NSE BSE
ortin laboratories ltd stock

ORTIN LABORATORIES LTD Share Price

- - (%)
- NSE: ORTINLAB

ORTIN LABORATORIES LTD Share Price Update

As of the latest trading session, ORTIN LABORATORIES LTD share price is currently at 18.29, which is down by -0.90 from its previous closing. Today, the stock has fluctuated between 18.19 and 19.50. Over the past year, ORTIN LABORATORIES LTD has achieved a return of -9.66 %. In the last month alone, the return has been -10.05 %. Read More...

ORTIN LABORATORIES LTD Performance

Day Range

Low18.19 High19.50
18.70

52 Week Range

Low 16.20 High 26.35
18.70

ORTIN LABORATORIES LTD Share Price

2979

539287

ORTINLAB

img img img img
No Data Available

Open Price

19.50

Prev. Close

19.20

Volume (Shares)

10330.00

Total traded value

1.93

Upper Circuit

23.04

Lower Circuit

15.36

Note: The current prices & values are delayed, Login to your account for live updates.

ORTIN LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 15.20
PE Ratio (TTM) 0.00
Book Value / Share 3.46
Beta 0.52
ROE -0.64%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -4.14

ORTIN LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 0.14
Operating Expense 3.49
Net Profit -4.14
Net Profit Margin (%) -2957.14
Earnings Per Share (EPS) -5.10
EBITDA -3.05
Effective Tax Rate (%) -30.50
Particulars DEC 2023 (Values in Cr)
Revenue 0.14
Operating Expense 2.94
Net Profit -2.79
Net Profit Margin (%) -1992.85
Earnings Per Share (EPS) -3.43
EBITDA -2.61
Effective Tax Rate (%) 0.71
Particulars SEP 2023 (Values in Cr)
Revenue 0.26
Operating Expense 1.36
Net Profit -1.12
Net Profit Margin (%) -430.76
Earnings Per Share (EPS) -1.38
EBITDA -0.90
Effective Tax Rate (%) -1.80
Particulars JUN 2023 (Values in Cr)
Revenue 1.57
Operating Expense 1.55
Net Profit 0.02
Net Profit Margin (%) 1.27
Earnings Per Share (EPS) 0.02
EBITDA 0.19
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 1.46
Operating Expense 1.67
Net Profit -0.20
Net Profit Margin (%) -13.69
Earnings Per Share (EPS) -0.25
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 2.11
Operating Expense 9.36
Net Profit -8.04
Net Profit Margin (%) -381.04
Earnings Per Share (EPS) -9.89
EBITDA -6.36
Effective Tax Rate (%) -13.70
Particulars MAR 2023 (Values in Cr)
Revenue 6.02
Operating Expense 6.15
Net Profit -0.09
Net Profit Margin (%) -1.49
Earnings Per Share (EPS) -0.12
EBITDA 0.54
Effective Tax Rate (%) 18.18
Particulars MAR 2022 (Values in Cr)
Revenue 8.23
Operating Expense 8.95
Net Profit -0.40
Net Profit Margin (%) -4.86
Earnings Per Share (EPS) -0.49
EBITDA 0.57
Effective Tax Rate (%) 24.52
Particulars MAR 2021 (Values in Cr)
Revenue 8.17
Operating Expense 8.08
Net Profit 0.95
Net Profit Margin (%) 11.62
Earnings Per Share (EPS) 1.16
EBITDA 1.30
Effective Tax Rate (%) -578.57
Particulars MAR 2020 (Values in Cr)
Revenue 197.39
Operating Expense 196.86
Net Profit -0.56
Net Profit Margin (%) -0.28
Earnings Per Share (EPS) -0.33
EBITDA 5.89
Effective Tax Rate (%) 177.77
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.36
ROE % -0.64
ROCE % 1.79
Total Debt to Total Equity 0.58
EBITDA Margin 9.30
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.47
ROE % -3.59
ROCE % 1.57
Total Debt to Total Equity 0.59
EBITDA Margin 6.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.97
ROE % 5.40
ROCE % 3.19
Total Debt to Total Equity 0.75
EBITDA Margin 15.79
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14.06
ROE % -2.29
ROCE % 8.74
Total Debt to Total Equity 0.80
EBITDA Margin 2.98
Particulars MAR 2019 (Values in Cr)
Book Value / Share 14.81
ROE % 5.21
ROCE % 11.19
Total Debt to Total Equity 0.75
EBITDA Margin 4.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 21.19
Total Liabilities 21.19
Total Equity 10.86
Share Outstanding 8131392
Price to Book Ratio 1.30
Return on Assets (%) -0.44
Return on Capital (%) -0.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.59
Total Assets 20.70
Total Liabilities 20.70
Total Equity 10.95
Share Outstanding 8131392
Price to Book Ratio 1.68
Return on Assets (%) -1.92
Return on Capital (%) -2.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 21.26
Total Liabilities 21.26
Total Equity 11.35
Share Outstanding 8131392
Price to Book Ratio 2.31
Return on Assets (%) 4.44
Return on Capital (%) 5.17
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.49
Total Assets 116.51
Total Liabilities 116.51
Total Equity 23.81
Share Outstanding 16940400
Price to Book Ratio 0.52
Return on Assets (%) -0.48
Return on Capital (%) -1.3
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 2.14
Total Assets 105.08
Total Liabilities 105.08
Total Equity 25.09
Share Outstanding 16940400
Price to Book Ratio 0.95
Return on Assets (%) 1.21
Return on Capital (%) 2.87
Particulars MAR 2023 (Values in Cr)
Net Income -0.11
Cash from Operations -0.25
Cash from Investing 0.00
Cash from Financing 0.90
Net change in Cash 0.65
Free Cash Flow -0.25
Particulars MAR 2022 (Values in Cr)
Net Income -0.52
Cash from Operations 2.14
Cash from Investing -0.12
Cash from Financing -0.47
Net change in Cash 1.55
Free Cash Flow 2.27
Particulars MAR 2021 (Values in Cr)
Net Income 0.13
Cash from Operations 18.03
Cash from Investing 0.06
Cash from Financing -9.85
Net change in Cash 8.24
Free Cash Flow 18.03
Particulars MAR 2020 (Values in Cr)
Net Income 0.71
Cash from Operations 4.13
Cash from Investing -3.09
Cash from Financing -1.33
Net change in Cash -1.12
Free Cash Flow 7.25
Particulars MAR 2019 (Values in Cr)
Net Income 1.83
Cash from Operations 6.94
Cash from Investing -3.26
Cash from Financing -2.88
Net change in Cash 0.36
Free Cash Flow 9.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
SANOFI INDIA LIMITED 6357.65 25.81 14.42 14641.67 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
ORTIN LABORATORIES LTD 18.94 0.00 5.45 15.40 16.15 / 26.39
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 19.10
  • 26 Days 19.50
  • 10 Days 19.40
  • 50 Days 19.20
  • 12 Days 19.50
  • 100 Days 19.40
  • 20 Days 19.80
  • 200 Days 19.30
19.34
PIVOT
First Resistance 19.69
Second Resistance 20.30
Third Resistance 20.65
First Support 18.73
Second Support 18.38
Third Support 17.77
RSI 42.57
MACD 0.07
Commodity Channel Index (CCI) -141.74
ADX 23.93
Williams % R -80.00

Over 1 Month

down

-10.05

Over 3 Months

down

-2.60

Over 6 Months

down

-10.95

Over 1 Year

down

-9.66

Over 3 Years

down

-19.61

Over 5 Years

down

9.27

ORTIN LABORATORIES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ORTIN LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
98.76
Promoter Holdings
1.23
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Prabha Rameshkumar Gupta Public Shareholding 400000.0 4.92
Rajesh Poddar Public Shareholding 381467.0 4.69
Seema Aggarwal Public Shareholding 200000.0 2.46
Nitin Sharma Public Shareholding 101000.0 1.24
Vivek Aggarwal Public Shareholding 100000.0 1.23
Soham Trading And Investments Pvt Ltd Public Shareholding 99309.0 1.22
Sanka Tandav Krishna Shareholding of Promoter and Promoter Group 40512.0 0.5
Venkata Sujatha Sanka Shareholding of Promoter and Promoter Group 21944.0 0.27
Lakshmi Sravani Dasari Shareholding of Promoter and Promoter Group 20000.0 0.25
Murali Krishna Murthy Sanka Shareholding of Promoter and Promoter Group 17844.0 0.22
Krishna Karthik Sanka Shareholding of Promoter and Promoter Group 0.0 0.0
Sanka Naga Jyothi Shareholding of Promoter and Promoter Group 0.0 0.0
Sanka Satya Praveen Kumar Shareholding of Promoter and Promoter Group 0.0 0.0
Sanka Ravi Sankar Shareholding of Promoter and Promoter Group 0.0 0.0
Sanka Hema Kumari Shareholding of Promoter and Promoter Group 0.0 0.0
Srinivasa Kumar Sanka Shareholding of Promoter and Promoter Group 0.0 0.0
Venkata Subbamma Sanka Shareholding of Promoter and Promoter Group 0.0 0.0
Venkata Ratnamma Sanka Shareholding of Promoter and Promoter Group 0.0 0.0
Sanka Sharath Kumar Shareholding of Promoter and Promoter Group 0.0 0.0
Balaji Venkateswarlu Sanka Shareholding of Promoter and Promoter Group 0.0 0.0

ORTIN LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2013-09-24 0.25 Final 2013-09-26 Equity shares 2012-09-24 0.5 Final 2012-09-26 Equity shares 2011-10-13 0.5 Final 2011-10-15 Equity shares 2010-09-23 0.8 Final 2010-09-25 Equity shares 2009-09-23 0.8 Final 2009-09-25 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ORTIN LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ORTIN LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ortin Laboratories Ltd?

Answer Field

The share price of Ortin Laboratories Ltd for NSE is ₹ 18.29 and for BSE is ₹ 18.35.

What is the Market Cap of Ortin Laboratories Ltd?

Answer Field

The market cap of Ortin Laboratories Ltd for NSE is ₹ 15.20 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Ortin Laboratories Ltd?

Answer Field

The 52 Week High and Low of Ortin Laboratories Ltd for NSE is ₹ 26.35 and ₹ 16.20 and for BSE is ₹ 26.39 and ₹ 16.15.

How to Buy Ortin Laboratories Ltd share?

Answer Field

You can trade in Ortin Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ortin Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -9.66%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader